Discordant Serology and Nucleic Acid Testing (NAT) Results for HIV, HBV and HCV in 2010

被引：0
|
作者：
Theodoropoulos, N. [1 ]
Nowicki, M. [3 ]
Chinchilla-Reyes, C. [3 ]
Pancoska, C. [4 ]
Jaramillo, A. [5 ]
Mone, T. [6 ]
Hasz, R. [7 ]
Jendrisak, M. D. [5 ]
Ladner, D. [2 ]
Ison, M. G. [1 ,2 ]
机构：
[1] Northwestern Univ, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Div Organ Transplantat, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Mendez Natl Inst Transplantat, Los Angeles, CA USA
[4] Labs Inc, Centennial, CO USA
[5] Gift Hope Organ & Tissue Donor Network, Itasca, IL USA
[6] OneLegacy, Los Angeles, CA USA
[7] Gift Life Donor Program, Philadelphia, PA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
4
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [41] Nucleic acid testing (NAT) for HCV RNA in Italian transfusion centres: An external quality assessment
    Candido, Angela
    Chionne, Paola
    Milazzo, Luisa
    Dettori, Stefano
    Madonna, Elisabetta
    Taffon, Stefania
    Kondili, Loreta A.
    Barca, Alessandra
    Hassan, Hamisa J.
    Rapicetta, Maria
    JOURNAL OF CLINICAL VIROLOGY, 2008, 41 (04) : 277 - 282
  • [42] Nucleic acid testing: the international status of NAT
    van der Poel, CL
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2001, 8 (03) : 240 - 241
  • [43] Assessment of an Automated HCV, HIV, and HBV NAT Donor Screening System
    Williams, J. Dunn
    Morgan, L.
    Spizman, R.
    Robertson, G. F.
    Dixon, M.
    Caglioti, S.
    TRANSFUSION, 2011, 51 : 207A - 208A
  • [44] HIV, HBV, AND HCV Screening with NATAND Serology in the OPO Setting.
    Theodoropoulos, Nicole
    Ison, Michael G.
    TRANSPLANTATION, 2018, 102 : S57 - S57
  • [45] Testing for HIV-1, HBV and HCV genomes using nucleic acid amplification techniques for red blood cell concentrates
    Lefevre, H
    Schottstedt, V
    Tuma, W
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1998, 25 (2-3): : 178 - 180
  • [46] REAL-TIME CONFIRMATION OF INITIALLY REACTIVE NAT RESULTS FOR HIV-1, HBV AND HCV USING PARALLEL NAT TESTING IN INCREASED-RISK ORGAN DONORS
    Cristina, Baleriola
    Sanghamitra, Ray
    Choy, Kok Chee
    Robert, Herkes
    Mathew, Law
    Michael, Ison G.
    William, Rawlinson D.
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : A16 - A16
  • [47] Cost-effectiveness (CE) of screening donated blood with minipool nucleic acid testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV)
    Grima, DT
    Marshall, D
    Weinstein, M
    Wong, JB
    Kleinman, S
    AuBuchon, J
    VALUE IN HEALTH, 2002, 5 (06) : 446 - 446
  • [48] HBV viremia preceding HBsAG positivity: Implications for minipool (MP) and individual donation (ID) HBV nucleic acid testing (NAT)
    Peddada, L
    Heldebrant, C
    Smith, R
    Conrad, A
    Raia, S
    Wright, D
    Fiebig, EW
    Busch, MP
    TRANSFUSION, 2000, 40 (10) : 14S - 15S
  • [49] Cost-effectiveness of nucleic acid testing for HIV and HCV in donated blood
    Jackson, BR
    Aubuchon, JP
    Busch, MP
    TRANSFUSION, 2000, 40 (10) : 138S - 138S
  • [50] Blood product and donor management based upon nucleic acid testing (NAT) results
    Fang, C
    Vargo, JM
    Smith, KM
    Mimms, L
    TRANSFUSION, 2001, 41 (09) : 82S - 82S
12345